Allogeneic transplantation in malignant lymphoma;Allogene transplantation maligner lymphome

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 39, 2001, Pages 1062-1069

  Stotzer O J ^a   Schleuning, M ^a   Ledderose, G ^a   Hiddemann, W ^a   Kolb, H J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; IMMUNOTHERAPY; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; LYMPHOMA, FOLLICULAR; LYMPHOMA, LOW-GRADE; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0035964708     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17492     Document Type: Article

References (38)

1. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma
2. Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning
3. Incidence of acute and chronic graft-versus-host disease after allogeneic peripheral blood stem cell and bone marrow transplantation: A meta-analysis
4. Allogeneic bone marrow transplantation for relapsed and refractrory Hodgkin's disease and non-Hodgkins lymphoma
5. Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia
6. Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT
7. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin'disease
8. Organisational Aspects. Paris: ESH
9. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
10. High dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease
11. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
12. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: Clinical and molecular follow-up
13. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based non-ablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
14. Allogeneic hematopoietic transplantation for mantle cell lymphoma
15. Allogeneic hematopoietic transplantation for indolent lymphomas
16. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease
17. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma
18. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia
19. Allogeneic bone marrow transplant is not better than autologous for patients with relapsed Hodgkin's disease
20. Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma
21. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma
22. Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
23. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases
24. Prospective comparative treal of autologous versus allogeneic bone marrow transplantation in patientes with non-Hodgkin's lymphoma
25. Higher than expected transplant related mortality and relapse following non-myeloablative stem cell transplantation for lymphoma adversely effects progression free survival
26. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia
27. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
28. Allogeneic bone marrow transplantation vs. Filgrastimmobilised peripheral blood progenitor cell transplantation in patients with early leukaemia
29. High dose therapy with allogeneic stem cell transplantation for relapsed mantle cell lymphoma: The Seattle experience
30. Intensified preparative regimens and allogeneic transplantation in refractory or relapsed intermediate and high grade non-Hodgkin's lymphoma
31. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation
32. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma
33. Allogeneic bone marrow transplantation for low-grade lymphoma
34. Allogeneic bone marrow transplantation for poor-prognosis lymphoma
35. Allogeneic bone marrow transplantation for low grade lymphoma
36. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma
37. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: Updated results of the Utrecht experience
38. Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation